Board of Directors
Carl Lindgren
Chairman of the Board since 2024. Board member since 2023. Born 1968.More than 25 years of experience in senior commercial positions within the Life Science industry, including roles at AstraZeneca, Lundbeck, Karo Healthcare, and EQL Pharma.
Education: B.Sc., Business Administration and Economics, Lund University
Other assignments: Board member BioMedica AB, Chief Business Development Officer at EQL Pharma
Holding: 744,527 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Mats Johansson
Chairman of the Board 2013-2020. Board member 2021. Born 1961.
Over 30 years of experience in founding and long-term development of companies, as well as listing companies on Nasdaq Stockholm.
Education: High School
Other assignments: Chairman of the Board, Abraxas Holding AB, Easy Depot AB, Volubus AB, and SiB Solutions AB. Board member, Klarabo Sverige AB, Nudging Capital AB.
Holding: 3,864,622 shares
Dependent in relation to the Company’s major shareholders and the Company and management.
Orest Lastow
Board member since 2013. Born 1964.
Over 30 years of experience in inhaled pharmaceuticals, has invented around 30 inhalers, including all of Iconovo’s inhalation platforms. Author of over 50 patent applications and several research articles and books.
Education: MSc, Engineering Physics, Lund University. PhD, Aerosol Physics, Brunel University, London.
Other assignments: Board member, Lastow Consulting AB.
Holding: 826,400 shares
Dependent in relation to the Company’s major shareholders and the Company and management.
Berndt Axelsson
Board member since 2013. Born 1959.
20-year background in PwC as a management consultant. Has since worked in the industry as CFO and CEO with a focus on M&A, Legal & Risk, and international distribution.
Education: BA Economics, Växjö University
Other assignments: CEO and Board member, BAN Business Consulting AB. Chairman of the Board, INVID Jönköping AB, Nässjö Näringsliv AB.
Holding: 1,244,021 shares
Independent in relation to the Company’s major shareholders and the Company and management.
Erik Westerlund
Board member since 2025. Born 1978.
He has a solid background in real estate development and corporate finance, and is co-founder of Bolite, with prior experience from Savana, ABG, Catella, Carnegie, and Leimdörfer.
Education: Holds a M.Sc. in Business and Economics from Stockholm School of Economics with a focus on accounting and finance, and a Master of Laws (LL.M.) from Umeå University.
Other assignments: Chairman of the Board at Bolite Bostäder Holding AB. Board member of Bässkär AB, Rhestare AB, and Sjöhusen i Umeå AB. Deputy board member of Askporten AB, Bolite Bostäder Mgmt AB, Bolite Fastigheter AB, Bolite Fastigheter Holding AB, Bolite i Haninge AB, Bolite i Knivsta 2 AB, Bolite Invest AB, Bolite Utveckling 3 AB, Bolite Utveckling 4 AB, Bolite Utveckling 5 AB, Bolite Utveckling 6 AB, Bolite Utveckling AB, Furuporten AB, Kvartsporten AB, Lärkporten AB, PropLN AB, and Träporten AB.
Holding: 909,630 shares (via 50 procent ownership in Bolite Invest AB)
Independent in relation to the Company’s major shareholders and the Company and management.
Andreas Engström
Board member since 2025. Born 1973.
20 years of experience in the pharmaceutical industry, both within regulatory authorities and the private sector, with a focus on pricing, reimbursement, and health economics. He is currently Director of Health Economics and Outcomes Research for Central and Northern Europe at Alexion Pharma.
Education: Holds a M. Sc. in Business and Economics from the Stockholm School of Economics.
Other assignments: Board member of Bluefish Pharmaceuticals AB (publ) and Coruscant Access Excellence AB.
Holding: 278,356 shares
Independent in relation to the Company and management, but not to the Company’s major shareholders.
Emanuel Stihl
Board member since 2026. Born 1985.
More than 15 years of experience in venture capital, private equity and entrepreneurship, with a focus on growth companies within technology, healthcare and life sciences. Emanuel is Founding and Managing Partner at Fåhraeus Startup & Growth AB and Chief Investment Officer of Fårö Capital AB. He has led and participated in investments across a broad range of Nordic growth companies and currently serves on several company boards.
Education: Master of Technology Management, Lund University.
Other assignments: Founding & Managing Partner, Fåhraeus Startup & Growth AB; Chief Investment Officer, Fårö Capital AB; Chairman Cehckin.com, Board Member of Tendium AB and Airsonett AB.
Holding: 0
Independent in relation to the Company and management, but not to the Company’s major shareholders.